Clinical Trial

Metabolomic Analysis of Lung Cancer

Study Description

Metabolomic Analysis of Lung Cancer

The purpose of this study is to learn more about the metabolic properties of lung cancer cells.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

13-C-glucose

10 grams of 13-C-glucose intravenously, as a 30-minute "piggyback" infusion, 2 to 6 hours prior to scheduled surgical resection of primary lung cancer.

Additional Information

Official Study Title

Preoperative Metabolomic Analysis of Primary Lung Cancer: A Translational Clinical Trial of the Brown Cancer Center

Clinical Trial ID

NCT00263731

ParticipAid ID

mbkR5a